Microfluidic Chip can Capture Live Tumor Cells in the Blood

by Kathy Jones on  August 10, 2013 at 10:53 PM Cancer News   - G J E 4
A new study published in the journal Biomicrofluidics reports on the development of a new microfluidic chip that efficiently segregated and captured live circulating tumor cells (CTCs) from a cancer patient's blood, opening up potential applications for cancer screenings and treatment assessments.
 Microfluidic Chip can Capture Live Tumor Cells in the Blood
Microfluidic Chip can Capture Live Tumor Cells in the Blood

Many currently available devices for detecting CTCs in patients' blood are either too slow for clinical use or have other problems, such as a reduced ability to distinguish between the rare CTCs and more common white blood cells and other non-tumor cells.

The new system captures more than 90 percent of the CTCs, which makes it highly efficient. Overall processing time has also been shortened, thanks in part to a step in which red blood cells are selectively lysed, or broken apart. Lysing the red blood cells diminishes the tendency of blood to clog the system, a common problem that slows processing time in similar CTC filtering devices.

The ability to count live, individual CTCs in the bloodstream can help doctors determine the severity of a cancer, since CTC density in the blood is linked to the progression of the disease and patients' likelihood of survival. The new method could also improve "liquid biopsy" techniques, in which a small amount of blood is drawn as an alternative to conventional tissue biopsies of primary or metastatic tumors.

In addition to potentially improving screening tests, the team believes their approach may someday help doctors control CTC-induced metastasis, which the researchers say can be far more lethal than the original tumor.

"Because our chip is able to capture viable CTCs, it creates opportunities for the development of new and efficient cancer biomarkers," says co-author Ray Han, a professor at Peking University in Beijing. It also gives researchers a chance to realize what Han calls "the grandest dream of all: a technology capable of directly removing CTCs from the human bloodstream - a form of CTC dialysis."

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All